Last reviewed · How we verify

NCT06658418

Erector Spinae Plane Block with Dexmedetomidine and Bupivacain Versus Dexamethasone and Bupivacain for Postoperative Analgesia in Patients Undergoing Abdominal Surgeries

Not yet recruiting Phase 1 Last updated 26 October 2024
What this trial tests

Phase 1 trial testing Erector Spinae Plane Block in Analgesia, Postoperative in 90 participants. Not yet recruiting.

Timeline
1 November 2024
Primary endpoint
1 November 2026
1 December 2026

Quick facts

Lead sponsorLoay Gamal
PhasePhase 1
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment90
Start date1 November 2024
Primary completion1 November 2026
Estimated completion1 December 2026

Drugs / interventions tested

Conditions studied

Sponsor

Loay Gamal

Who can join

Adults 18 to 65, any sex, with Analgesia, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the analgesic effect of dexmedetomidine combined with bupivacaine versus dexamethasone combined with bupivacaine for ultrasound-guided ESPB for postoperative pain control in patients scheduled for abdominal surgeries

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Erector Spinae Plane Block

Trials testing the same drug.

Other recruiting trials for Analgesia, Postoperative

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06658418.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing